Terkko Navigator / Journal of Clinical Psychopharmacology

An Introduction and My Vision for JCP.

In Memoriam: Frederick King Goodwin (1936-2020).

James (Jeff) Walter Jefferson, MD.

Comparison of the Metabolic Characteristics of Newer Second Generation Antipsychotics: Brexpiprazole, Lurasidone, Asenapine, Cariprazine, and Iloperidone With Olanzapine as a Comparator.

Guideline Adherence of Monitoring Antipsychotic Use for Nonpsychotic Indications in Children and Adolescents: A Patient Record Review.

Clozapine Response in Schizophrenia and Hematological Changes.

Nanocurcumin as an Add-on to Antipsychotic Drugs for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study.

Prolactin and Estrogen Levels in Postmenopausal Women Receiving Aripiprazole Augmentation Treatment for Depression.

Cost of the Illness of Treatment-Resistant Schizophrenia: A Mirror Image Study Comparing Clozapine With Other Antipsychotics.

The Effect of Add-on Buprenorphine to Matrix Program in Reduction of Craving and Relapse Among People With Methamphetamine Use Disorder: A Randomized Controlled Trial.

Influence of Different Antidepressants on Ocular Surface in Patients With Major Depressive Disorder.

No Effect of Coenzyme Q10 on Cognitive Function, Psychological Symptoms, and Health-related Outcomes in Schizophrenia and Schizoaffective Disorder: Results of a Randomized, Placebo-Controlled Trial.

Finding Early Improvement Threshold to Predict Response After 8 Weeks of Treatment Using Risperidone in First-Episode Psychosis.

Tolerability of High-Dose Venlafaxine After Switch From Escitalopram in Nonresponding Patients With Major Depressive Disorder.

Covert Dyskinesia With Aripiprazole: Tip of the Iceberg? A Case Report and Literature Review.

A Systematic Review on the Efficacy of Intravenous Racemic Ketamine for Bipolar Depression.

Reanalysis of a Phase 3 Trial of a Monthly Extended-Release Risperidone Injection for the Treatment of Acute Schizophrenia.

Delayed-Onset Severe Neutropenia Associated With Clozapine With Successful Rechallenge at Lower Dose.

Intravenous Augmentative Valproate Versus Delorazepam in Bipolar Patients With a Major Depressive Mixed Episode and Partial/Nonresponse to Oral Treatment: A Pilot Study.

Rapid Improvement of Treatment-Resistant Major Depression During the Administration of Low-Dose Oxycodone.

Treatment of Opioid Use Disorder Attributed to Fentanyl With High-Dose Buprenorphine: A Case Report.

Memantine for Behavioral Symptoms of Hepatic Encephalopathy Associated With Alcoholic Cirrhosis: A Case Report.

Intranasal Oxytocin and Social Interactions in 5 Patients With High-Functioning Autism Spectrum Disorder.

Buspirone Abuse by Insufflation: A Case Report.

Recurrent Suicidal Ideation With Topiramate in Tourette Syndrome.

Advantageous Add-on Duloxetine to Aripiprazole-Responsive Early-Onset Schizophrenia.

Abilify MyCite (Aripiprazole): A Critical Evaluation of the Novel Dosage Form.

An Introduction and My Vision for JCP.

In Memoriam: Frederick King Goodwin (1936-2020).

James (Jeff) Walter Jefferson, MD.

Comparison of the Metabolic Characteristics of Newer Second Generation Antipsychotics: Brexpiprazole, Lurasidone, Asenapine, Cariprazine, and Iloperidone With Olanzapine as a Comparator.

Guideline Adherence of Monitoring Antipsychotic Use for Nonpsychotic Indications in Children and Adolescents: A Patient Record Review.

Clozapine Response in Schizophrenia and Hematological Changes.

Nanocurcumin as an Add-on to Antipsychotic Drugs for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study.

Prolactin and Estrogen Levels in Postmenopausal Women Receiving Aripiprazole Augmentation Treatment for Depression.

Cost of the Illness of Treatment-Resistant Schizophrenia: A Mirror Image Study Comparing Clozapine With Other Antipsychotics.

The Effect of Add-on Buprenorphine to Matrix Program in Reduction of Craving and Relapse Among People With Methamphetamine Use Disorder: A Randomized Controlled Trial.

Influence of Different Antidepressants on Ocular Surface in Patients With Major Depressive Disorder.

No Effect of Coenzyme Q10 on Cognitive Function, Psychological Symptoms, and Health-related Outcomes in Schizophrenia and Schizoaffective Disorder: Results of a Randomized, Placebo-Controlled Trial.

Finding Early Improvement Threshold to Predict Response After 8 Weeks of Treatment Using Risperidone in First-Episode Psychosis.

Tolerability of High-Dose Venlafaxine After Switch From Escitalopram in Nonresponding Patients With Major Depressive Disorder.

Covert Dyskinesia With Aripiprazole: Tip of the Iceberg? A Case Report and Literature Review.

A Systematic Review on the Efficacy of Intravenous Racemic Ketamine for Bipolar Depression.

Reanalysis of a Phase 3 Trial of a Monthly Extended-Release Risperidone Injection for the Treatment of Acute Schizophrenia.

Delayed-Onset Severe Neutropenia Associated With Clozapine With Successful Rechallenge at Lower Dose.

Intravenous Augmentative Valproate Versus Delorazepam in Bipolar Patients With a Major Depressive Mixed Episode and Partial/Nonresponse to Oral Treatment: A Pilot Study.

Rapid Improvement of Treatment-Resistant Major Depression During the Administration of Low-Dose Oxycodone.

Treatment of Opioid Use Disorder Attributed to Fentanyl With High-Dose Buprenorphine: A Case Report.

Memantine for Behavioral Symptoms of Hepatic Encephalopathy Associated With Alcoholic Cirrhosis: A Case Report.

Intranasal Oxytocin and Social Interactions in 5 Patients With High-Functioning Autism Spectrum Disorder.